Global Immuno Oncology Assay Market, By Technology (Immunoassay, PCR, Others), By Product Type (Consumables, Software), By Indication (Melanoma, Others), By Application (Clinical Diagnostics, Research Applications), Estimation & Forecast, 2019 – 2026

pa_user-types

Check Today's Best Price

$3500 Buy Now
The Global Immuno Oncology Assay Market held a market size of $3.1 billion in 2019 and is anticipated to grow at a CAGR of 13% from 2019 to 2026.
  • Market Dynamics

    The global immuno oncology assay market held a market size of $3.1 billion in 2019 and is anticipated to grow at a CAGR of 13% from 2019 to 2026.

    Immuno oncology assays are used majorly for the diagnosis of cancer. Immuno oncology utilizes the body’s natural defenses to target and destroys cancer cells. The immuno oncology assay market is witnessing growth due to the increasing research & development activities in the field of cancer. These assays are widely used in clinical trials as they increase the efficiency of experiments and also reduces the cost of research and manual labor. Further, the increasing government initiatives for the biotechnology sector are expected to provide a favorable environment for market growth. Moreover, the rising incidence of cancer across the globe is driving the growth of the market. According to the American Cancer Society, about 1.8 million new cancer cases are expected to be diagnosed in the U.S. in the year 2020. In addition, the adoption of targeted therapy has increased in recent years. This factor is expected to support market growth.  Despite the drivers, a huge amount of capital investment and unfavorable reimbursement scenario may hamper the market growth over the assessment period.

    Market Segmentation

    The global immuno oncology assay market has been divided into technology, product type, indication, and application.

    The technology segment has been segmented into immunoassay, PCR, next-generation sequencing (Ngs), flow cytometry, and others. The Polymerase chain reaction (PCR) segment is expected to hold a major share in the market owing to the growing use of PCR while conducting oncology diagnosis and research. The product type segment has been segmented into consumables and software. The consumables segment is expected to hold substantial market share owing to the availability of kits and reagents and the growing use of regents in various oncology treatments. Further, the growing research on cancer immunotherapy is expected to support the market segment. The indication segment has been divided into colorectal cancer, melanoma, lung cancer, and others. Further, the application segment has been bifurcated into clinical diagnostics and research applications. The research application segment is expected to dominate the market based on application. The growing number of clinical trials and the development of biomarker-based drugs is supporting the growth of this segment.

    Regional Analysis

    On a regional basis, the immuno oncology assay market has been divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America has been classified into the U.S. and Canada. Europe region has been divided into the UK, France, Italy, Germany, and the Rest of Europe. Asia-Pacific region has been bifurcated into, Japan, India, South Korea, China, and Rest of Asia-Pacific. Moreover, the South America region has been bifurcated into Brazil, Mexico, Argentina, and the Rest of South America. Further, the Middle East & Africa has been segmented into GCC countries, Africa, and the Rest of the Middle East.

    North America is expected to be the dominating region in the global immuno oncology assay market followed by Europe. In North America, the presence of developed healthcare infrastructure, high acceptance for advanced devices in the medical field, and increasing prevalence of cancer are driving the market growth. The Asia Pacific is expected to be the fastest-growing region in the global immuno oncology assay market. The increasing number of clinical research organizations in the region coupled with growing awareness about early detection of cancer is supporting the market growth in the region. Moreover, the increasing shift of market players’ focus from developed countries to emerging economies and high disease burden is also fueling the growth of the market.

    Competitive Landscape

    Key players operating in the global market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Roche Diagnostics, Illumina, Inc., Sartorius AG, Nanostring Technologies, Inc., Foundation Medicine, Qiagen, Merck, HTG Molecular Diagnostics, Inc., and Perkin Elmer. These players are engaged in new product launches, partnerships, merger & acquisitions to strengthen its market presence.

    Recent Market Developments by Key Players

    • In January 2020, Roche and Illumina, Inc. entered into a partnership aimed at boosting the adoption of next-generation sequencing assays in the oncology field.
    • In November 2019, Illumina, Inc. stated the forthcoming introduction of TruSight Oncology 500 ctDNA, the company’s first liquid biopsy product for the detection of cancer biomarkers.
    • In July 2019, Agilent Technologies, Inc. announced the acquisition of BioTek Instruments. With this acquisition, Agilent strengthens its position in the cell analysis segment.
    • In May 2019, Agilent Technologies, Inc. introduced a unique product portfolio for immunotherapy researchers.

    Key Segments:

    By Technology

    • Immunoassay
    • PCR
    • Next-Generation Sequencing (Ngs)
    • Flow Cytometry
    • Others

    By Product Type

    • Consumables
    • Software

    By Indication

    • Colorectal Cancer
    • Melanoma
    • Lung Cancer
    • Others

    By Application

    • Clinical Diagnostics
    • Research Applications

    By Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • U.K
      • Germany
      • France
      • Italy
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • South Korea
      • Rest of Asia Pacific
    • South America
      • Brazil
      • Argentina
      • Mexico
      • Rest of South America
    • Middle East & Africa
      • GCC Countries
      • Africa
      • Rest of Middle East

    Frequently Asked Questions (FAQ):

    What is the size of the global immuno oncology assay market?

    The size of the global immuno oncology assay market in 2019 was $3.1 billion.

    Who are the major companies operating in the global immuno oncology assay market?

    Prominent companies operating in the global immuno oncology assay market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Roche Diagnostics, Illumina, Inc., Sartorius AG, Foundation Medicine, Qiagen, Merck, HTG Molecular Diagnostics, Inc., Nanostring Technologies, Inc., and Perkin Elmer.

    keyboard_arrow_up
  • Table of Content

    1. Market Introduction
    1.1. Executive Summary
    1.2. Market Definition
    1.3. Market Scope

    2. Research Methodology
    2.1. Primary Research
    2.2. Research Methodology
    2.3. Assumptions & Exclusions
    2.4. Secondary data Indications

    3. Global Immuno Oncology Assay Market Overview
    3.1. Report Segmentation & Scope
    3.2. Key Market Trend
    3.3. Drivers
    3.4. Restraints
    3.5. Opportunities
    3.6. Porter’s Five Forces Analysis
    3.6.1. Bargaining Power of Supplier
    3.6.2. Bargaining Power of Buyer
    3.6.3. Threat of Substitute
    3.6.4. Threat of New Entrants
    3.6.5. Competitive Rivalry
    3.7 PESTEL Analysis
    3.7.1. Political Landscape
    3.7.2. Economic Landscape
    3.7.3. Technological Landscape
    3.7.4. Environmental Landscape
    3.7.5. Social Landscape
    3.8. Market Share Analysis

    4. Global Immuno Oncology Assay Market, By Technology
    4.1. Overview
    4.2. Immunoassay
    4.2.1. Market Size & Forecast, 2019-2026
    4.3. PCR
    4.3.1. Market Size & Forecast, 2019-2026
    4.4. Next-Generation Sequencing (Ngs)
    4.4.1 Market Size & Forecast, 2019-2026
    4.5. Flow Cytometry
    4.5.1 Market Size & Forecast, 2019-2026
    4.6 Others

    5. Global Immuno Oncology Assay Market, By Product Type
    5.1. Overview
    5.2. Consumables
    5.2.1 Market Size & Forecast, 2019-2026
    5.3. Software
    5.3.1 Market Size & Forecast, 2019-2026

    6. Global Immuno Oncology Assay Market, By Indication
    6.1. Overview
    6.2. Colorectal Cancer
    6.2.1 Market Size & Forecast, 2019-2026
    6.3. Melanoma
    6.3.1 Market Size & Forecast, 2019-2026
    6.4. Lung Cancer
    6.4.1 Market Size & Forecast, 2019-2026
    6.5. Others
    6.5.1 Market Size & Forecast, 2019-2026

    7. Global Immuno Oncology Assay Market, By Application
    7.1. Overview
    7.2. Clinical Diagnostics
    7.2.1 Market Size & Forecast, 2019-2026
    7.3. Research Applications
    7.3.1 Market Size & Forecast, 2019-2026

    8. Global Immuno Oncology Assay Market, Region
    8.1. Overview
    8.1.1. Global Market Size & Forecast, 2019-2026
    8.2. North America Immuno Oncology Assay Market
    8.2.1. North America Market Size & Forecast, 2019-2026, By Country
    8.2.2. North America Market Size & Forecast, 2019-2026, By Product Type
    8.2.3. North America Market Size & Forecast, 2019-2026, By Technology
    8.2.4. North America Market Size & Forecast, 2019-2026, By Application
    8.2.5. North America Market Size & Forecast, 2019-2026, By Indication
    8.2.6. U.S.
    8.2.6.1. Market Size and Forecast, 2019-2026, By Product Type
    8.2.6.2. Market Size and Forecast, 2019-2026, By Technology
    8.2.6.3. Market Size and Forecast, 2019-2026, By Application
    8.2.6.4. Market Size and Forecast, 2019-2026, By Indication
    8.2.7. Canada
    8.2.7.1. Market Size and Forecast, 2019-2026, By Product Type
    8.2.7.2. Market Size and Forecast, 2019-2026, By Technology
    8.2.7.3. Market Size and Forecast, 2019-2026, By Application
    8.2.7.4. Market Size and Forecast, 2019-2026, By Indication
    8.3. Europe Immuno Oncology Assay Market
    8.3.1. Europe Market Size & Forecast, 2019-2026, By Country
    8.3.2. Europe Market Size & Forecast, 2019-2026, By Product Type
    8.3.3. Europe Market Size & Forecast, 2019-2026, By Technology
    8.3.4. Europe Market Size & Forecast, 2019-2026, By Application
    8.3.5. Europe Market Size & Forecast, 2019-2026, By Indication
    8.3.6. Germany
    8.3.6.1. Market Size and Forecast, 2019-2026, By Product Type
    8.3.6.2. Market Size and Forecast, 2019-2026, By Technology
    8.3.6.3. Market Size and Forecast, 2019-2026, By Application
    8.3.6.4. Market Size and Forecast, 2019-2026, By Indication
    8.3.7. France
    8.3.7.1. Market Size and Forecast, 2019-2026, By Product Type
    8.3.7.2. Market Size and Forecast, 2019-2026, By Technology
    8.3.7.3. Market Size and Forecast, 2019-2026, By Application
    8.3.7.4. Market Size and Forecast, 2019-2026, By Indication
    8.3.8. UK
    8.3.8.1. Market Size and Forecast, 2019-2026, By Product Type
    8.3.8.2. Market Size and Forecast, 2019-2026, By Technology
    8.3.8.3. Market Size and Forecast, 2019-2026, By Application
    8.3.8.4. Market Size and Forecast, 2019-2026, By Indication
    8.3.9. Italy
    8.3.9.1. Market Size and Forecast, 2019-2026, By Product Type
    8.3.9.2. Market Size and Forecast, 2019-2026, By Technology
    8.3.9.3. Market Size and Forecast, 2019-2026, By Application
    8.3.9.4. Market Size and Forecast, 2019-2026, By Indication
    8.3.10. Spain
    8.3.9.1. Market Size and Forecast, 2019-2026, By Product Type
    8.3.10.2. Market Size and Forecast, 2019-2026, By Technology
    8.3.10.3. Market Size and Forecast, 2019-2026, By Application
    8.3.10.4. Market Size and Forecast, 2019-2026, By Indication
    8.3.11. Rest of Europe
    8.3.11.1. Market Size and Forecast, 2019-2026, By Product Type
    8.3.11.2. Market Size and Forecast, 2019-2026, By Technology
    8.3.11.3. Market Size and Forecast, 2019-2026, By Application
    8.3.11.4. Market Size and Forecast, 2019-2026, By Indication
    8.4. Asia-Pacific Immuno Oncology Assay Market
    8.4.1. Asia-Pacific Market Size & Forecast, 2019-2026, By Country
    8.4.2. Asia-Pacific Market Size & Forecast, 2019-2026, By Product Type
    8.4.3. Asia-Pacific Market Size & Forecast, 2019-2026, By Technology
    8.4.4. Asia-Pacific Market Size & Forecast, 2019-2026, By Application
    8.4.5. Asia-Pacific Market Size & Forecast, 2019-2026, By Indication
    8.4.6. Japan
    8.4.6.1. Market Size and Forecast, 2019-2026, By Product Type
    8.4.6.2. Market Size and Forecast, 2019-2026, By Technology
    8.4.6.3. Market Size and Forecast, 2019-2026, By Application
    8.4.6.4. Market Size and Forecast, 2019-2026, By Indication
    8.4.7. China
    8.4.7.1. Market Size and Forecast, 2019-2026, By Product Type
    8.4.7.2. Market Size and Forecast, 2019-2026, By Technology
    8.4.7.3. Market Size and Forecast, 2019-2026, By Application
    8.4.7.4. Market Size and Forecast, 2019-2026, By Indication
    8.4.8. Australia
    8.4.8.1. Market Size and Forecast, 2019-2026, By Product Type
    8.4.8.2. Market Size and Forecast, 2019-2026, By Technology
    8.4.8.3. Market Size and Forecast, 2019-2026, By Application
    8.4.8.4. Market Size and Forecast, 2019-2026, By Indication
    8.4.9. India
    8.4.9.1. Market Size and Forecast, 2019-2026, By Product Type
    8.4.9.2. Market Size and Forecast, 2019-2026, By Technology
    8.4.9.3. Market Size and Forecast, 2019-2026, By Application
    8.4.9.4. Market Size and Forecast, 2019-2026, By Indication
    8.4.10. South Korea
    8.4.10.1. Market Size and Forecast, 2019-2026, By Product Type
    8.4.10.2. Market Size and Forecast, 2019-2026, By Technology
    8.4.10.3. Market Size and Forecast, 2019-2026, By Application
    8.4.10.4. Market Size and Forecast, 2019-2026, By Indication
    8.4.11. Rest of Asia-Pacific
    8.4.11.1. Market Size and Forecast, 2019-2026, By Product Type
    8.4.11.2. Market Size and Forecast, 2019-2026, By Technology
    8.4.11.3. Market Size and Forecast, 2019-2026, By Application
    8.4.11.4. Market Size and Forecast, 2019-2026, By Indication
    8.5. South America Immuno Oncology Assay Market
    8.5.1. South America Market Size & Forecast, 2019-2026, By Country
    8.5.2. South America Market Size & Forecast, 2019-2026, By Product Type
    8.5.3. South America Market Size & Forecast, 2019-2026, By Technology
    8.5.4. South America Market Size & Forecast, 2019-2026, By Application
    8.5.5. South America Market Size & Forecast, 2019-2026, By Indication
    8.5.6. Brazil
    8.5.6.1. Market Size and Forecast, 2019-2026, By Product Type
    8.5.6.2. Market Size and Forecast, 2019-2026, By Technology
    8.5.6.3. Market Size and Forecast, 2019-2026, By Application
    8.5.6.4. Market Size & Forecast, 2019-2026, By Indication
    8.5.7. Argentina
    8.5.7.1. Market Size and Forecast, 2019-2026, By Product Type
    8.5.7.2. Market Size and Forecast, 2019-2026, By Technology
    8.5.7.3. Market Size and Forecast, 2019-2026, By Application
    8.5.7.4. Market Size & Forecast, 2019-2026, By Indication
    8.5.8. Rest of South America
    8.5.8.1. Market Size and Forecast, 2019-2026, By Product Type
    8.5.8.2. Market Size and Forecast, 2019-2026, By Technology
    8.5.8.3. Market Size and Forecast, 2019-2026, By Application
    8.5.8.4. Market Size & Forecast, 2019-2026, By Indication
    8.6. Middle East & Africa Immuno Oncology Assay Market
    8.6.1. Middle East & Africa Market Size & Forecast, 2019-2026, By Country
    8.6.2. Middle East & Africa Market Size & Forecast, 2019-2026, By Product Type
    8.6.3. Middle East & Africa Market Size & Forecast, 2019-2026, By Technology
    8.6.4. Middle East & Africa Market Size & Forecast, 2019-2026, By Application
    8.6.5. Middle East & Africa Market Size & Forecast, 2019-2026, By Indication
    8.6.6. GCC Countries
    8.6.6.1. Market Size and Forecast, 2019-2026, By Product Type
    8.6.6.2. Market Size and Forecast, 2019-2026, By Technology
    8.6.6.3. Market Size and Forecast, 2019-2026, By Application
    8.6.6.4. Market Size and Forecast, 2019-2026, By Indication
    8.6.7. Africa
    8.6.7.1. Market Size and Forecast, 2019-2026, By Product Type
    8.6.7.2. Market Size and Forecast, 2019-2026, By Technology
    8.6.7.3. Market Size and Forecast, 2019-2026, By Application
    8.6.5.4. Market Size and Forecast, 2019-2026, By Indication
    8.6.8. Rest of Middle East
    8.6.8.1. Market Size and Forecast, 2019-2026, By Product Type
    8.6.8.2. Market Size and Forecast, 2019-2026, By Technology
    8.6.8.3. Market Size and Forecast, 2019-2026, By Application
    8.6.5.4. Market Size and Forecast, 2019-2026, By Indication

    9. Company Profile
    9.1. Agilent Technologies, Inc.
    9.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    9.1.2. Product, Type, Category, and Specification
    9.1.3. Financial Performance
    9.1.4. Strategic Initiatives
    9.2. Thermo Fisher Scientific, Inc.
    9.3. Roche Diagnostics
    9.4. Illumina, Inc.
    9.5. Sartorius AG
    9.6 Nanostring Technologies, Inc.
    9.7 Foundation Medicine
    9.8 Qiagen
    9.9 Merck
    9.10 HTG Molecular Diagnostics, Inc.
    9.11 Perkin Elmer

    10. List of Tables
    Table 1 Global Immuno Oncology Assay Market Share, By Product Type, 2016-2026 ($Billion)
    Table 2 Global Immuno Oncology Assay Market Share, By Technology, 2016-2026 ($Billion)
    Table 3 Global Immuno Oncology Assay Market Share, By Application, 2016-2026 ($Billion)
    Table 4 Global Immuno Oncology Assay Market Share, By Indication, 2016-2026 ($Billion)
    Table 5 Global Immuno Oncology Assay Market Value, 2016-2026 ($Billion)
    Table 6 North America, Immuno Oncology Assay Market Value and Growth Rate, 2016-2026 ($Billion)
    Table 7 North America, Immuno Oncology Assay Market Share Value, By Country, 2016-2026 ($Billion)
    Table 8 North America Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 9 North America Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 10 North America Immuno Oncology Assay Market Share Value, By Application 2016-2026 ($Billion)
    Table 11 North America Immuno Oncology Assay Market Share Value, By Indication 2016-2026 ($Billion)
    Table 12 U.S. Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 13 U.S. Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 14 U.S. Immuno Oncology Assay Market Share Value, By Application 2016-2026 ($Billion)
    Table 15 U.S. Immuno Oncology Assay Market Share Value, By Indication 2016-2026 ($Billion)
    Table 16 Canada Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 17 Canada Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 18 Canada Immuno Oncology Assay Market Share Value, By Application 2016-2026 ($Billion)
    Table 19 Canada Immuno Oncology Assay Market Share Value, By Indication 2016-2026 ($Billion)
    Table 20 Europe Immuno Oncology Assay Market Value and Growth Rate, 2016-2026 ($Billion)
    Table 21 Europe Immuno Oncology Assay Market Share Value, By Country, 2016-2026 ($Billion)
    Table 22 Europe Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 23 Europe Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 24 Europe Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 25 Europe Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 26 UK Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 27 UK Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 28 UK Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 29 UK Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 30 Germany Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 31 Germany Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 32 Germany Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 33 Germany Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 34 France Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 35 France Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 36 France Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 37 France Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 38 Italy Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 39 Italy Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 40 Italy Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 41 Italy Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 42 Rest of Europe Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 43 Rest of Europe Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 44 Rest of Europe Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 45 Rest of Europe Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 46 Asia Pacific Immuno Oncology Assay Market Value and Growth Rate, 2016-2026 ($Billion)
    Table 47 Asia Pacific Immuno Oncology Assay Market Share Value, By Country, 2016-2026 ($Billion)
    Table 48 Asia Pacific Immuno Oncology Assay Market Share Value, By Product Type , 2016-2026 ($Billion)
    Table 49 Asia Pacific Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 50 Asia Pacific Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 51 Asia Pacific Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 52 Asia Pacific Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 53 India Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 54 India Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 55 India Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 56 India Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion))
    Table 57 China Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 58 China Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 59 China Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 60 China Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 61 Japan Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 62 Japan Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 63 Japan Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 64 Japan Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 65 South Korea Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 66 South Korea Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 67 South Korea Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 68 South Korea Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 69 Rest of Asia Pacific Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 70 Rest of Asia Pacific Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 71 Rest of Asia Pacific Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 72 South Korea Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 73 South America Immuno Oncology Assay Market Value and Growth Rate, 2016-2026 ($Billion)
    Table 74 South America Immuno Oncology Assay Market Share Value, By Country, 2016-2026 ($Billion)
    Table 75 South America Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 76 South America Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 77 South America Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 78 South America Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 79 Brazil Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 80 Brazil Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 81 Brazil Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 82 Brazil Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 83 Argentina Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 84 Argentina Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 85 Argentina Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 86 Argentina Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 87 Mexico Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 88 Mexico Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 89 Mexico Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 90 Mexico Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 91 Rest of South America, Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 92 Rest of South America Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 93 Rest of South America Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 94 Rest of South America Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 95 Middle East & Africa Immuno Oncology Assay Market Value and Growth Rate, 2016-2026 ($Billion)
    Table 96 Middle East & Africa Immuno Oncology Assay Market Share Value, By Country, 2016-2026 ($Billion)
    Table 97 Middle East & Africa Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 98 Middle East & Africa Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 99 Middle East & Africa Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 100 Middle East & Africa Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 101 GCC Countries Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 102 GCC Countries Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 103 GCC Countries Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 104 GCC Countries Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 105 Africa Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 106 Africa Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 107 Africa Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 108 Africa Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 109 Rest of Middle East Immuno Oncology Assay Market Share Value, By Product Type, 2016-2026 ($Billion)
    Table 110 Rest of Middle East Immuno Oncology Assay Market Share Value, By Technology, 2016-2026 ($Billion)
    Table 111 Rest of Middle East Immuno Oncology Assay Market Share Value, By Application, 2016-2026 ($Billion)
    Table 112 Rest of Middle East Immuno Oncology Assay Market Share Value, By Indication, 2016-2026 ($Billion)
    Table 113 Recent Developments

    11. List of Figures
    Figure 1 Global Immuno Oncology Assay Market Overview
    Figure 2 Global Immuno Oncology Assay Market Segmentation
    Figure 3 Global Immuno Oncology Assay Market Drivers
    Figure 4 Global Immuno Oncology Assay Market Restraints
    Figure 5 Global Immuno Oncology Assay Market Porter’s Analysis
    Figure 6 Global Immuno Oncology Assay Market share, By Product Type, 2018 VS 2026 (%)
    Figure 7 Global Immuno Oncology Assay Market share, By Technology, 2018 VS 2026 (%)
    Figure 8 Global Immuno Oncology Assay Market share, By Application, 2018 VS 2026 (%)
    Figure 9 Global Immuno Oncology Assay Market share, By Indication, 2018 VS 2026 (%)
    Figure 10 U.S. Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 11 Canada Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 12 U.K. Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 13 Germany Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 14 France Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 15 Italy Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 16 Rest of Europe Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 17 India Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 18 China Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 19 Japan Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 20 South Korea Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 21 Rest of Asia Pacific Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 22 Brazil Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 23 Argentina Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 24 Rest of South America Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 25 GCC Countries Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 26 Africa Immuno Oncology Assay Market share, 2016-2026 ($Billion)
    Figure 27 Rest of Middle East Immuno Oncology Assay Market share, 2016-2026 ($Billion)

    keyboard_arrow_up
  • Agilent Technologies, Inc.
    Thermo Fisher Scientific, Inc.
    Roche Diagnostics
    Illumina, Inc.
    Sartorius AG
    Foundation Medicine
    Qiagen
    Merck
    HTG Molecular Diagnostics, Inc.
    Nanostring Technologies, Inc.
    Perkin Elmer

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

  • What was the market size of the Immuno Oncology Assay Market in 2020 and the expected market size by 2026, along with the growth rate?
  • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
  • Which are the largest revenue generating products, services or regions and their comparative growth rate?
  • Which technology is in trend and how would it evolve during the forecast period (2019– 2026)?
  • Which are the leading companies in the Immuno Oncology Assay Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS

SHARE YOUR CART